Meeting Banner
Abstract #1002

Reduced Cerebral GABA in Patients with Amnestic Mild Cognitive Impairment (AMCI) May Predict Progression to Alzheimers Disease (AD)

Napapon Sailasuta1, Kent Harris1, Ralph Noeske2

1HMRI, Pasadena, CA, United States; 2Research and Collaboration, GE Healthcare, Berlin, Germany

We report GABA concentration is reduced in amnestic mild cognitive impaired subjects and proposed that GABA can be used as marker for AD.

Keywords

accounts acid acquisition adult alike alone amino arch array assess assessment assist assistance authors become best bipolar brain cairns carried carry cell cerebellum cerebral challenge chandler channel classification clinical clinicians cognitive coil collaboration combination combined concentrations condition correlation cortex cortical decreased defining dementia detection determination diagnoses discovery disease disorder disorders drug dysfunction elderly engineered enrolled established evidence family foundation gamma gene genetic genetically hardy head healthy human hypothesized impairment impairs inhibitory innervation intensity invasive knowledge late like living loss major measure mega mice mild monitoring neurons neuropathology neurotransmitter none numerous occipital onset patients plot posterior postmortem precursor predict preliminary press processing progression quantification reception recognized recorded reduced regression reported ring risk sage scanner scatter serve seven several significance significantly simple software spectra spectroscopic spectrum stage statistics stem student studies subjects supported syndrome temporal thalamus thank therapeutic thereby typical unsuppressed useful volunteers water wester